GSK on trial over Seroxat

GSK on trial over Seroxat

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:18 pm #1


 



A BOLTON woman is heading for a High Court showdown with pharmaceutical giant GlaxoSmithKline in a bid for compensation.

Lawyers for Veronica Howarth say in a writ issued at London's High Court that she has suffered undisclosed personal injuries after taking the widely prescribed anti-depressant drug Seroxat, also known as paroxetine.

Now, Mrs Howarth, of The Sheddings, Bolton, is claiming damages of up to £50,000 from the manufacturers. She is one of the latest in a group of several hundred people who want to sue the drug manufacturer, claiming their lives have been blighted by addiction to the drug.

 

Seroxat is designed to restore the taker's happiness and confidence, but some people have claimed they have been addicted to it, while others have experienced suicidal tendancies.

GlaxoSmithKline is contesting the legal action.

A spokesman said: "We believe there is no merit in this litigation. Seroxat has benefited millions of people worldwide who have suffered from depression."

However, Mark Harvey, a solicitor acting for many of the claimants said: "All the claimants allege that they tried to withdraw from Seroxat and have suffered discontinuation syndrome."

A procedural judge will decide the initial stages of the case and how the action will go ahead.

A discussion of how the case will be managed is expected soon
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:21 pm #2


<SCRIPT language=JavaScript>
<!--

function SymError()
{
return true;
}

window.onerror = SymError;

var SymRealWinOpen = window.open;

function SymWinOpen(url, name, attributes)
{
return (new Object());
}

window.open = SymWinOpen;

//-->
</SCRIPT>

<SCRIPT language=JavaScript>
<!--
function ascreen() {
window.open('blank.htm', 'ascreen1', 'width=605,height=470,scrollbars=no,resizable=yes');
}
function ascreen1() {
window.open('blank.htm', 'ascreen1', 'width=605,height=470,scrollbars=no,resizable=yes');
}
//-->

</SCRIPT>
&nbsp;


<TABLE>
<TBODY>
<TR>
<TD>
<TD>
<TR>
<TD>[url=javascript:history.back(1)][/url]</FONT> </TD></TR></TBODY></TABLE>
<FONT face=ARIAL size=-1><FONT size=4><FONT color=#000099>Mark Harvey</FONT>

<FONT size=2><FONT color=#000099><FONT size=3>Company</FONT></FONT>
Hugh James Solicitors

<FONT color=#000099><FONT size=3>Address</FONT></FONT>
<IMG alt="Mark Harvey" hspace=10 src="http://www.richardgrandsociety.com/imag ... Harvey.jpg" align=right>
Hodge House
114 - 116 St. Mary Street
Cardiff
CF10 1DY



Tel: 029 2022 4871
Fax: 029 2038 8222
e-mail: [url=mailto:Mark.Harvey@hughjames.com]Mark.Harvey@hughjames.com[/url]

website: www.hjfs.co.uk


<FONT color=#000099><FONT size=3>Responsibilities</FONT></FONT>
Mark Harvey is the partner in charge of the Product Liability section of the Claimant Division of Hugh James in Cardiff, a member of the Legal Services Commission’s Multi-Party Solicitors’ Panel.

He has obtained compensation for many individual victims of common but defective consumer products. He is presently representing over 1000 claimants in actions arising out of the Seroxat and Vioxx pharmaceutical products as well as in three Group Actions concerning medical devices. Most recently he negotiated a settlement protocol for patients who alleged visual problems from their cataract remedial intraocular lenses.

He is a past Secretary of the Association of Personal Injury Lawyers as well as being a Fellow of APIL, one of the two UK Governors of the American Association for Justice (formerly ATLA) and a member of the Civil Justice Council.

Author of the APIL Guide to Conditional Fees and the contributor of the Group Actions and Product Liability chapters in the APIL Personal Injury Guide both published by Jordans; he is also the contributing author of the Marketing chapter of the Law Society’s Civil Litigation Handbook (2nd Edition) and Board Member of the Journal of Personal Injury Law.

He has been described as a "Leader in Personal injury and Product Liability" in Chambers and Partners and the Legal 500 during 1999-2007. In 2005 he surprised many including him when nominated as Wales’ only entry in The Lawyer’s “Hot 100” and even more so in 2006 when invited to appear in Debrett’s People of Today!

<FONT color=#000099><FONT size=3>Career Overview</FONT></FONT>
Mark Harvey was admitted in 1990 as a Solicitor having begun his career in London as a Trainee Legal Executive in 1980 with Owen White, qualifying as a Legal Executive in 1987 working on high street legal aid personal injury claims as well as the Opren group action.

From 1990-94 he was with Lawford & Co, representing major Trade Unions in South Wales including electrical, banking and local government unions, developing an amusing practice representing British Airways stewardesses!

He joined the Smith Llewelyn Partnership in 1994 to revive his personal and professional relationship with the firm (with whom he had litigated the Opren anti-arthritis drug litigation from 1982 until 1987). He became a partner there in 1995.

In May 2001, he became a partner in the Claimant Division of Hugh James in Cardiff, with whom he had been co-ordinating the Gerona air crash claims.

He has represented victims in most of the travel disasters of the 1980s and 1990s, including Zeebrugge, Clapham, P & O Lifeboat accident in Cherbourg, and the Maidenhead rail fire. He was a member of the Steering Committees for both the Southall and Ladbroke Grove rail crashes.

He represented Ricky Evans, the first international rugby player to successfully sue another for injury occurring during an international rugby match. He has obtained compensation for many individual victims of common but defective consumer products. He is presently representing over 1000 claimants in actions arising out of the Seroxat and Vioxx pharmaceutical products as well as in three Group Actions concerning various injuries and complaints with medical devices. Most recently he negotiated a settlement protocol for patients who alleged visual problems from their cataract remedial intraocular lenses.

He is past Secretary of the Association of Personal Injury Lawyers (APIL) and now a Fellow of APIL; member of the Civil Justice Council and one of the two UK Governors of the American Association for Justice, (formerly known as ATLA) as well as being Vice President of Cardiff and District Law Society.

Author of the APIL Guide to Conditional Fees and the contributor of the Group Actions and Product Liability chapters in the APIL Personal Injury Guide both published by Jordans; he is also the contributing author of the Marketing chapter of the Law Society’s Civil Litigation Handbook (2nd Edition) and Board Member of the Journal of Personal Injury Law.

He has lectured extensively around Britain, mainland Europe and the US on personal injury matters, is a regular author of articles in legal journals and broadcasts regularly on television and radio.Despite this, he finds time to enjoy playing football and golf well as cooking and enjoying wine appreciation.

He has been described as a "Leader in Personal Injury and Product Liability" in Chambers and Partners and the Legal 500 during 1999-2007. In 2005 he surprised many including him when nominated as Wales’ only entry in The Lawyer’s “Hot 100” and even more so in 2006 when invited to appear in Debrett’s People of Today! ENDS

</TD></TR></TABLE><MAP name=menu><AREA shape=RECT coords=3,8,93,32 href="index.ihtml"><AREA shape=RECT coords=3,36,93,58 href="about.ihtml"><AREA shape=RECT coords=3,60,93,80 href="whatsnew.ihtml"><AREA shape=RECT coords=3,110,93,132 href="merchant.ihtml"><AREA shape=RECT coords=3,136,93,156 href="specials.ihtml"><AREA shape=RECT coords=3,160,93,180 href="new.ihtml"><AREA shape=RECT coords=3,184,93,204 href="search.ihtml"><AREA shape=RECT coords=3,208,93,232 href="basket.ihtml"></MAP>
<SCRIPT language=JavaScript>
<!--
var SymRealOnLoad;
var SymRealOnUnload;

function SymOnUnload()
{
window.open = SymWinOpen;
if(SymRealOnUnload != null)
SymRealOnUnload();
}

function SymOnLoad()
{
if(SymRealOnLoad != null)
SymRealOnLoad();
window.open = SymRealWinOpen;
SymRealOnUnload = window.onunload;
window.onunload = SymOnUnload;
}

SymRealOnLoad = window.onload;
window.onload = SymOnLoad;

//-->
</SCRIPT>
</FONT></FONT></FONT>
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:23 pm #3


<SPAN class=newsProvider>The Mail on Sunday - Jan. 20, 2008</SPAN>
<DIV class=newsContent align=justify><BLOCK id=a61544793>
<P lede="true">MURDERER Colin Dorey, who battered his wife to death with a hammer, is suing pharmaceuticals giant GlaxoSmithKline over his use of the anti-depressant Seroxat.

<P lede="true">From his cell at Gartree Prison in Leicestershire, the 48-year-old chef - jailed in 2002 for murdering his wife Christine, 37, at their Suffolk home - has joined nearly 500 other users of the drug in a GBP30million lawsuit against the multi-national, each seeking compensation of up to GBP50,000.

<P class=newsContent>Their case, funded by legal aid, is expected to cost the taxpayer hundreds of thousands of pounds.

<P class=newsContent>Law firm Hugh James, on behalf of the ...


<TABLE height=1 cellSpacing=0 cellPadding=0 width=500>
<TBODY>
<TR>
<TD width=13 height=1><IMG height=1 src="http://www.therapeuticsdaily.com/images/ui/TD_frames/hr_left.gif" width=13></TD>
<TD background=http://www.therapeuticsdaily.com/images/ui/TD_frames/hr_dot.gif height=1><IMG height=1 src="http://www.therapeuticsdaily.com/images/ui/TD_frames/hr_dot.gif" width=474></TD>
<TD width=13 height=1><IMG height=1 src="http://www.therapeuticsdaily.com/images/ui/TD_frames/hr_right.gif" width=13></TD></TR></TBODY></TABLE></DIV>
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:25 pm #4

<FONT color=#7777cc size=-1>« View all web results for seroxat</FONT>
<DIV class=mainbody></DIV>
<DIV class=mainbody>
<TABLE cellSpacing=0 cellPadding=0>
<TBODY>
<TR>
<TD align=left>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE>
<TABLE cellSpacing=7 cellPadding=2 border=0 valign="top">
<TBODY>
<TR>
<TD class=j vAlign=top>
</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<P style="MARGIN-LEFT: 9px"><FONT color=#ff0000>New!</FONT> Get the <FONT color=#0000cc>latest news on seroxat</FONT> with Google Alerts.


</DIV>
<SCRIPT>function clicked(ln, label, ctr, cid, sig) {return function() {var npp = '';var und_pos = cid.indexOf('_');if (und_pos != -1) {npp = cid.substring(und_pos+1);cid = cid.substring(0, und_pos);}var click_params = "ct=uk/"+label+"-"+ctr+"&fp=47a15add86957e80&ei=I-ihR4GBD5L6_AHWkum9DQ&url="+escape(ln.href).replace(/\+/g,"%2b").replace(/\#/g,"%23")+"&cid="+cid;if (npp != '')click_params += "&npp=" + npp;if (sig != '')click_params += "&sig2=" + sig;(new Image()).src="/news/url?sa=T&"+click_params;return true;}}if (document.images) {var h = location.hostname;var nln = document.links.length;var label = '';var cid = '';var ctr = 0;for (var i = 0; i < nln; ++i) {var ln = document.links;var sig = '';if (ln.id) {var id = ln.id;if (id.substring(0,2) == 's-') {colon_pos = id.indexOf(':');if (colon_pos == -1) {sig = id.substring(2);id = '';} else {sig = id.substring(2, colon_pos);id = id.substring(colon_pos+1);}}if (id.substring(0,2) != 'r-') {if (sig == '')continue;} else {var und_pos = id.indexOf('_');if (und_pos == -1) {label = id.substring(2);} else {label = id.substring(2, und_pos);cid = id.substring(und_pos+1);}ctr = 0;}} else if (ln.host == h || ln.hostname == h || ! label || ! cid ||ln.host == "www.google.com" || ln.hostname == "www.google.com") {continue;}ln.onmousedown = clicked(ln, label, ctr++, cid, sig);}}</SCRIPT>

<DIV class=n id=navbar>
<TABLE cellSpacing=0 cellPadding=0 width="1%" align=center border=0>
<TBODY>
<TR vAlign=top align=middle>
<TD vAlign=bottom noWrap><FONT size=-1>Result&nbsp;Page:&nbsp;</FONT>
<TD noWrap><IMG height=26 alt="" src="http://news.google.co.uk/nav_first.gif" width=18>

<TD noWrap><IMG height=26 alt="" src="http://news.google.co.uk/nav_current.gif" width=16>
</TD></TR></TBODY></TABLE></DIV>
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:26 pm #5

just like all the other fat cat's
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:28 pm #6

&nbsp;



A BOLTON woman is heading for a High Court showdown with pharmaceutical giant GlaxoSmithKline in a bid for compensation.

Lawyers for Veronica Howarth say in a writ issued at London's High Court that she has suffered undisclosed personal injuries after taking the widely prescribed anti-depressant drug Seroxat, also known as paroxetine.

Now, Mrs Howarth, of The Sheddings, Bolton, is claiming damages of up to £50,000 from the manufacturers. She is one of the latest in a group of several hundred people who want to sue the drug manufacturer, claiming their lives have been blighted by addiction to the drug.

&nbsp;

Seroxat is designed to restore the taker's happiness and confidence, but some people have claimed they have been addicted to it, while others have experienced suicidal tendancies.

GlaxoSmithKline is contesting the legal action.

A spokesman said: "We believe there is no merit in this litigation. Seroxat has benefited millions of people worldwide who have suffered from depression."

However, Mark Harvey, a solicitor acting for many of the claimants said: "All the claimants allege that they tried to withdraw from Seroxat and have suffered discontinuation syndrome."

A procedural judge will decide the initial stages of the case and how the action will go ahead.

A discussion of how the case will be managed is expected soon
<IMG height=520 src="http://i193.photobucket.com/albums/z313/fiddy64/me.jpg" width=390>

Bob Fiddaman
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:29 pm #7




&nbsp;

Strange blue woman
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:31 pm #8

Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:39 pm #9

&nbsp;



A BOLTON woman is heading for a High Court showdown with pharmaceutical giant GlaxoSmithKline in a bid for compensation.

Lawyers for Veronica Howarth say in a writ issued at London's High Court that she has suffered undisclosed personal injuries after taking the widely prescribed anti-depressant drug Seroxat, also known as paroxetine.

Now, Mrs Howarth, of The Sheddings, Bolton, is claiming damages of up to £50,000 from the manufacturers. She is one of the latest in a group of several hundred people who want to sue the drug manufacturer, claiming their lives have been blighted by addiction to the drug.

&nbsp;

Seroxat is designed to restore the taker's happiness and confidence, but some people have claimed they have been addicted to it, while others have experienced suicidal tendancies.

GlaxoSmithKline is contesting the legal action.

A spokesman said: "We believe there is no merit in this litigation. Seroxat has benefited millions of people worldwide who have suffered from depression."

However, Mark Harvey, a solicitor acting for many of the claimants said: "All the claimants allege that they tried to withdraw from Seroxat and have suffered discontinuation syndrome."

A procedural judge will decide the initial stages of the case and how the action will go ahead.

A discussion of how the case will be managed is expected soon
<IMG title="BNF 4.3 - Antidepressants - Top_5_Drugs_92_06" alt="BNF 4.3 - Antidepressants - Top_5_Drugs_92_06" src="http://www.isdscotland.org/isd/images/BNF4.3_Top_5_Drugs_Px_92_93_04_06.gif" border=0>
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

January 31st, 2008, 3:41 pm #10


&nbsp;

http://fiddaman.blogspot.com/2008/01/pe ... rt-ii.html

&nbsp;

Oh dear Oh dear! Have the staff at the MHRA nothing better to do with themselves?

There's me thinking they were out busting small online pharmacies - you know, the kind that are a threat to the major pharmaceutical companies... they are supposed to be buried in over one million pieces of paperwork regarding their current sham of an investigation into GlaxoSmithKline too. So what are they doing today people?

Let's see shall we.


18. 30 January 09:22 Exponential-e Customer Allocation, London, London, City of, United Kingdom
21. 30 January 10:12 Exponential-e Customer Allocation, London, London, City of, United Kingdom
22. 30 January 10:16 Exponential-e Customer Allocation, London, London, City of, United Kingdom
23. 30 January 10:19 Exponential-e Customer Allocation, London, London, City of, United Kingdom
24. 30 January 10:22 Exponential-e Customer Allocation, London, London, City of, United Kingdom
37. 30 January 14:03 Exponential-e Customer Allocation, London, London, City of, United Kingdom
38. 30 January 14:05 Exponential-e Customer Allocation, London, London, City of, United Kingdom
39. 30 January 14:05 Exponential-e Customer Allocation, London, London, City of, United Kingdom
40. 30 January 14:08 Exponential-e Customer Allocation, London, London, City of, United Kingdom
41. 30 January 14:09 Exponential-e Customer Allocation, London, London, City of, United Kingdom
42. 30 January 14:10 Exponential-e Customer Allocation, London, London, City of, United Kingdom
43. 30 January 14:11 Exponential-e Customer Allocation, London, London, City of, United Kingdom
44. 30 January 14:12 Exponential-e Customer Allocation, London, London, City of, United Kingdom
45. 30 January 14:14 Exponential-e Customer Allocation, London, London, City of, United Kingdom
46. 30 January 14:15 Exponential-e Customer Allocation, London, London, City of, United Kingdom

Busy reading this blog. Now it may be a coincidence but I asked my MP, Gisela Stuart to ask the Dept of Health what the benefir of Seroxat was... The MHRA can't/won't answer you see. Maybe that is what is eating at the MHRA who seem to access my blog via this page <STRONG><FONT color=#4386ce>here</FONT></STRONG>.

Oh, incidently - The Department of Health have been looking in today too.


25. 30 January 10:27 DEPARTMENT OF HEALTH, Fiskerton Ferry, Nottinghamshire, United Kingdom
29. 30 January 12:04 DEPARTMENT OF HEALTH, Fiskerton Ferry, Nottinghamshire, United Kingdom
31. 30 January 12:04 DEPARTMENT OF HEALTH, Fiskerton Ferry, Nottinghamshire, United Kingdom

Maybe they are researching what the benefit of Seroxat is?

They won't find the answer on here. They won't get the answer off the MHRA either!

Still awaiting your response to my emails Mr Kent Woods - you can't tell me you haven't had time now can you?

Good day to you all
Quote
Like
Share